Although Helicobacter pylori infection is both a common and a serious bacterial infection,
antimicrobial therapies have rarely been optimized, are prescribed empirically, and provide …

Helicobacter pylori is an important pathogen whose primary niche is the human stomach. H.
pylori is etiologically associated with gastric inflammation (gastritis), peptic ulcer disease, …

Background and Aims: Fluoroquinolone‐containing regimens have been suggested as an
alternate to standard triple therapy for the treatment of Helicobacter pylori infections. To …

Background and Aim: Helicobacter pylori eradication clearly decreases peptic ulcer recurrence
rates. H. pylori eradication is achieved in 70–90% of cases, but treatment failures due to …

Objectives To elucidate the relationship between the mutations of penicillin-binding protein (PBP)1,
PBP2 and PBP3 and amoxicillin resistance in Helicobacter pylori. Methods The …

Background and Aim: Helicobacter pylori (H. pylori) eradication rates using the PPI/AC
regimen (proton pump inhibitor + amoxicillin + clarithromycin) are declining. We trialed tailoring …

The major cause of chemotherapy failure in patients with chronic gastritis and peptic ulcers
caused by Helicobacter pylori is clarithromycin (CAM) resistance due to a mutation in the 23S …

Helicobacter suis, a bacterial species naturally hosted by pigs, can colonize the human
stomach in the context of gastric diseases such as gastric mucosa-associated lymphoid tissue (…

Increased resistance of Helicobacter pylori to clarithromycin and metronidazole has resulted
in recommendation to substitute fluoroquinolones for eradication therapy. The aims of the …

Genetic analysis and culturing techniques for gastric non-Helicobacter pylori Helicobacter (NHPH)
are progressing. NHPH is reported to accompany nodular gastritis, gastric MALT …